Disclosure Of Interests In Other Entities [Text Block]

ERYTECH Pharma S.A. - Filing #2810992

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
16 219 EUR
42 634 EUR
40 048 EUR
Non-current assets
35 088 EUR
3 177 EUR
26 720 EUR
Current liabilities
15 264 EUR
11 678 EUR
20 005 EUR
Non-current liabilities
10 429 EUR
10 646 EUR
23 918 EUR
Profit (loss)
23 488 EUR
23 488 EUR
228,000 EUR
228,000 EUR
53 797 EUR
53 797 EUR
Comprehensive income
23 652 EUR
23 488 EUR
49,000 EUR
EUR
213,000 EUR
EUR
EUR
194,000 EUR
235,000 EUR
228,000 EUR
EUR
187,000 EUR
53 797 EUR
68,000 EUR
EUR
528,000 EUR
EUR
54 257 EUR
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
164,000 EUR
49,000 EUR
213,000 EUR
422,000 EUR
235,000 EUR
187,000 EUR
68,000 EUR
528,000 EUR
460,000 EUR
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
10 474 EUR
38 789 EUR
33 699 EUR
44 446 EUR
Tax expense (income)
208,000 EUR
521,000 EUR
2,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.